DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0) (BioCAD00000021333)

blood feces all tissues

Metabolite Card

Formula: C43H72O5 (668.5379)
SMILES: [H][C@](CO)(COC(=O)CCC\C=C/C\C=C/C\C=C/CCCCCCCC)OC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC

Synonyms [en]

DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0); 1-meadoyl-2-homo-g-linolenoyl-sn-glycerol; DG(40:6); Diglyceride; DAG(40:6); (2S)-3-hydroxy-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propyl (5Z,8Z,11Z)-icosa-5,8,11-trienoate

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021333). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position and one chain of homo-g-linolenic acid at the C-2 position. The mead acid moiety is derived from fish oils, liver and kidney, while the homo-g-linolenic acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

  • CAS Registry Number:
  • PubChem CID: 53478254
  • ChEBI: 89785
  • HMDB: HMDB0007459
  • LipidMaps:
  • KEGG:
  • BioCyc:
  • NCBI MeSH:
  • Wikipedia:
Other DBLinks
  • PubChem: 53478254
  • ChEBI: ChEBI:89785
  • HMDB: HMDB0007459
  • HMDB: HMDB07459
  • Metlin: METLIN_58964
  • Coconut NaturalProduct: CNP0084140.1

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0067860 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0067864 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:2(13Z,16Z))
PathBank:SMP0067868 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0034906 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0034910 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PathBank:SMP0034914 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:2(13Z,16Z))
PathBank:SMP0034918 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0076608 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0076612 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0076616 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/24:0)
PathBank:SMP0086377 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0091882 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0091886 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0091890 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/24:0)
PathBank:SMP0067859 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PathBank:SMP0067863 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:1(13Z))
PathBank:SMP0067867 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0034905 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
PathBank:SMP0034909 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
PathBank:SMP0034913 De Novo Triacylglycerol Biosynthesis TG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/22:1(13Z))
View All Pathways